Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Interest Expense

$0.00

TTM · Period ending: Jun 30, 2026 · USD

LCTX Interest Expense

Latest reported$0.00period endingJun 30, 2026

Latest reported$0.00period endingJun 30, 2026

LCTX Interest Expense ($0.00 → $0.00)

Annual interest expense

High-resolution chart · PNG

LCTX interest expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Interest Expense — Annual fiscal periods (USD)
Period ending	Interest Expense (USD)
Dec 31, 2025	0
Dec 31, 2024	0
Dec 31, 2023	0
Dec 31, 2022	0
Dec 31, 2021	0
Dec 31, 2020	0
Dec 31, 2019	0
Dec 31, 2018	10,872,000
Dec 31, 2017	692,000
Dec 31, 2016	747,000
Dec 31, 2015	340,000
Dec 31, 2014	91,047
Dec 31, 2013	26,090,756
Dec 31, 2012	305,183
Dec 31, 2011	0
Dec 31, 2010	124,300
Dec 31, 2009	1,653,755
Dec 31, 2008	965,781
Dec 31, 2007	0
Dec 31, 2006	157,114
Dec 31, 2005	78,978
Dec 31, 2004	0
Dec 31, 2003	1,090,612
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	0
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.